Concepedia

Sergey O. Kulyk

SO

Statistics

Publications

3

Citations

2K

H-Index

3

Active since

2014

Affiliations

Comprehensive Blood & Cancer Center(Current)

Comprehensive Cancer Centers of Nevada

University of California, Los Angeles

Cancer Trials Ireland

Petz Aladár Megyei Oktató Kórház

Sergey O. Kulyk is an author at Comprehensive Blood & Cancer Center specializing in molecular oncology, pharmacology, and medicine.

Publications per year

2014–2017

3

Publications

3

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

Richard S. Finn, John Crown, István Láng et al. · The Lancet Oncology · 2014 · 1.9K citations

, , +17

Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs letrozole alone for frontline treatment of ER+/HER2– advanced breast cancer (PALOMA-1; TRIO-18).

Richard S. Finn, John Crown, István Láng et al. · Journal of Clinical Oncology · 2017 · 67 citations

, , +12

Abstract CT101: Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)

Richard S. Finn, John Crown, István Láng et al. · Cancer Research · 2014 · 51 citations

, , +17

1–3 of 3